Print This PageBookmark this PageEmail this Page

Dr. Nossa's Curriculum Vitae


Dermatology. Mount Sinai School of Medicine. New York, New York. (1998-2001) {Chief Resident 2000-2001}


Internal Medicine. Brown University, School of Medicine, Department of Internal Medicine. Providence, Rhode Island. (1997-1998)


M.D. State University of New York at Stony Brook, School of Medicine. Stony Brook, New York. (1993-1997)
B.A. Political Science Manhattanville College, Purchase, New York. (1987-1992)

Board Certification

Diplomat American Board of Dermatology

Hospital Staff

The Mountainside Hospital, Montclair, NJ (973) 429-6000
St. Barnabas Medical Center, Livingston, NJ (973) 322-5000
Mount Sinai School of Medicine, New York, NY
Clinical Instructor – Mount Sinai School of Medicine

Memberships in Professional Societies

American Academy Dermatology
American Society of Dermatologic Surgery
New Jersey Dermatological Society

Research and Clinical Trials

Role: Principal Investigator

Qualitative Assessment of MelaFind® in the Clinical Setting
Sponsor: MELA Sciences, Inc.
January 2012 – February 2012

A Phase 3 Multicenter Study of the Efficacy and Safety of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa.
Sponsor: Abbott Laboratories
October 2011 – Ongoing

A randomized, double-blind, multicenter study of subcutaneous secukinumab, assessing Psoriasis Area and Severity Index (PASI) response and maintenance of response in subjects with moderate to severe chronic plaque—type psoriasis on either a fixed dose regimen or on a retreatment at start of relapse regimen.
Sponsor: Novartis Pharmaceutical, Inc.
August 2011 – Ongoing

A Phase I, Clinical Trial to Evaluate Sweat Production In Subjects With Primary Axillary Hyperhidrosis in Adults.
Anterios, Inc.
July 2011 – December 2011

A Phase I, Clinical Trial to Evaluate Botulinum Neurotoxin Type A (ANT–1207) In Subjects with Acne.
Anterios, Inc.
July 2011 – November 2011

A Randomized, Double–Blind, Vehicle–Controlled, Multi–Center Study to Evaluate the Efficacy and Safety of AN2690 Topical Solution, 5% vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenail in Adults
Sponsor: Anacor Pharmaceuticals
January 2011 – Ongoing

Calcipotriol Plus Betamethasone Dipropionate Topical Suspension Compared to Betamethasone Dipropionate in the Topical Suspension Vehicle, Calcipotriol in the Topical Suspension Vehicle and the Topical Suspension Vehicle Alone in Psoriasis Vulgaris
Sponsor: Leo Pharmaceuticals
September 2011 – June 2011

A Multicenter, Open Registry of Patients with Psoriasis Who Are Candidates for Systemic Therapy Including Biologics
Sponsor: Janssen Biotech, Inc.
June 2010 – Ongoing

A Phase III, Mulitcenter, Randomized, Double–Blind Study Evaluating the Safety and Efficacy of IDP–108 Topical Solution vs. Vehicle in Subjects with Mild to Moderate Onychomycosis of the Toenails
Sponsor: Dow Pharmaceutical Sciences, Inc.
November 2009 – December 2011

A 10–Year Post–Marketing, Observational, Registry of HUMIRA® (Adalimumab) in Adult Patients with Chronic Plaque Psoriasis
Sponsor: Abbott Laboratories
November 2009 – Ongoing

Pre–Commercial Qualitative Assessment of MelaFind® in the Clinical Setting
Sponsor: MELA Sciences, Inc.
September 2010 – December 2010.

A Phase II, Multicenter, Randomized, Double–Blind, Parallel–Group, Comparative Study of FV–100 vs. Valacyclovir in Patients with Herpes Zoster
Sponsor: Inhibitex, inc.
October 2009 – October 2010.

A Prospective, Multicenter, Parallel, Randomized, Blinded Study of the Efficacy and Safety of the DTS G2 System in Patients with Axillary Hyperhidrosis (Pivitol)
Sponsor: Miramar Labs, Inc.
June 2009 – February 2011.

Clinical Evaluation of the DTS–G2 in Patients with Hyperhidrosis (Feasibility)
Sponsor: Miramar Labs, Inc.
February 2009 – June 2010.

*All listed investigations are in accordance with the Investigational Plan provided by the Study Sponsor, signed agreements, 21 CFR 812.2 (b), Abbreviated Requirements, the Declaration of Helsinki, and any conditions of approval imposed by reviewing IRB/EC or the U.S. Food and Drug Administration (FDA). Informed consent is obtained per applicable requirements.

Mount Sinai School of Medicine, Department of Dermatology
Mentor: James Spencer
 • Treatment of vitiligo with UV–308 laser phototherapy.
  August 1999 – March 2000. The purpose of this study was to evaluate the efficacy of UV–308
  laser phototherapy for the treatment of vitiligo. Acquired and treated patients; created data sheets;
  analyzed data; reviewed literature; prepared manuscripts for publication.

New York University, Oncology Section, Skin and Cancer Unit.
 • Large congenital melanocytic nevus follow-up study.
  June – September 1994. Reviewed historical literature on malignant melanoma evolving in large
  congenital melanocytic nevi, to supplement a NYU Melanoma Cooperative Group data base
  analysis. The study demonstrated that, based on a cumulative five year life–table analysis, our
  study population, with large congenital melanocytic nevi, had significantly increased risk for
  developing malignant melanoma.

New York University, Oncology Section, Skin and Cancer Unit.
 • Neoangiogenesis as a prognostic indicator in melanoma.
  September 1992 – July 1993. Created a study protocol, database, and data sheets to be used by
  histopathologists reviewing the cases. Reviewed the NYU Melanoma Cooperative Group data
  base for adequate case specimens. Responsible for collecting pertinent step sectioned histologic
  slides and verifying proper staining with Factor VII, CD–31, and CD–34 immunoperoxidase stains.

Licensure & Accreditation

State of New Jersey Medical Licensure
State of New York Medical Licensure


Nossa R "Laser Tattoo Removal". In Lasers and Non–Surgical Rejuvenation. First edition. DiBernardo B, Pozner, J. Saunders 2009.
Glaser DA, Coleman III WP, Fan LK, Kaminer MS, Kilmer SL, Nossa R, Smith SR, O'Shaughnessy SF. A Randomized, Blinded Clinical Evaluation of a Novel Microwave Device for Treating Axillary Hyperhidrosis: The Dermatologic Reduction in Underarm Perspiration Study. Derm Surg. February 2012; 38(2); 185-191
Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: A pilot study. J Am Acad Dermatol. 2002;46(5):727-731.
Marghoob AA, Blum R, Nossa R. Agminated Clark's Nevus: Case report and review of literature. Arch Dermatol. 2001;137:917-920.
Tarlow MM, Nossa R, Spencer JD. Effective management of difficult surgical defects using tissue engineered skin (Graftskin). Derm Surg. Dermatol Surg 2001; 27(1): 71-4.
Esser AC, Nossa R, Shoji T, Sapadin AN. All-Trans-retinoic acid induced scrotal ulcerations in a patient with acute promyelocytic leukemia. J Am Acad Dermatol 2000;43:316-17.
Gennarelli M, Nossa R, Marghoob AA. An irregular pigmented lesion in a child. Cortlandt forum. Accepted for publication December 1999.
Spencer J, Nossa R, Tse DT, Sequeira M. Sebaceous Carcinoma of the eyelid treated with Mohs surgery. Submitted for publication Aug 2000.
Gennarelli M, Nossa R, Marghoob AA. An irregular pigmented lesion in a child. Cortlandt forum. Accepted for publication December 1999.
Nossa R, Gordon M. First tinea, then scarring alopecia. Cortlandt forum. 1999;12:57-59
Rich JD, Mylonakis E, Nossa R, Chapnick. Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C. Dig Dis Sci 1999;44:1034-37.
Nossa R, Marghoob AA, Slade J, Kopf AW, Friedman RJ, Kaufmann E. "Atypical Mole Syndrome" in Melanoma 2000 (Completed 1998. Publication pending completion of textbook).
Marghoob AA, Nossa R, Kopf AW, Friedman RJ, Orlow S, Provost N, Kaufman E. "Congenital Melanocytic Nevi" in Melanoma 2000. (Completed 1998. Publication pending completion of textbook).
Sahin S, Rao B, Lee E, Kopf AW, Lee E, Rigel DS, Nossa R, Rahman IJ, Wortzel H, Marghoob AA, Bart RS. Predicting ten-year survival of patients with primary cutaneous melanoma. Cancer 1997;80:1426-31.
Rao B, Trager J, Nossa R, Granstein R, Scott R. Blistering Disorder in a 30 month-old boy. Journal of Cutaneous Medicine and Surgery. 1997:2;30-34.
Marghoob AA, Schoenbach S, Kopf AW, Orlow SJ, Nossa R. Large Congenital melanocytic nevi and the risk of developing malignant melanoma: A prospective study . Archives of Dermatology 1996;132:170-75.
Friedman RJ, Rigel DS, Silverman S, Nossa R. "Malignant Melanoma." In: Dermatologic Surgery: Principles and Practice. Second edition. Roenigk RK, Roenigk HH. Dekker, 1996.
Friedman RJ, Rigel DS, NossaR, Dorf R. "Basal Cell and Squamous Cell Carcinoma." In: UIAA Handbook of Oncology. 1996.
Friedman RJ, Rigel DS, Kopf AW, Berson D, Nossa R, Dorf R. "Basal Cell and Squamous Cell Carcinoma." In: American Cancer Society: Textbook of Clinical Oncology. Second edition. American Cancer Society. 1995.

Back to Top